Combined prevention and treatment measures are essential to control nosocomial infections during the COVID-19 pandemic

doi:10.5501/wjv.v13.i2.91286

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (495)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

HTML

239

Figures (1-1)

Tables (1-2)

Sum=347

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=114

Publishing Process of This Article

Item

Count

Browse

Download

Sum=21

Jun 25, 2024 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Virol. Jun 25, 2024; 13(2): 91286
Published online Jun 25, 2024. doi: 10.5501/wjv.v13.i2.91286

Table 2 Drugs information

Therapeutic drugs	Mechanism
Remdesivir	Inhibiting virus replication
Molnupiravir	Inhibiting virus replication
Paxlovid	Inhibiting virus replication
Bamlanivimab/Etesevimab	Blocking the binding of viruses to host cells
Casirivimab/Imdevimab	Blocking the binding of viruses to host cells
Cyclosporin	Inhibiting overactivated immune system
Recovery period plasma therapy	Antibodies that neutralize viruses

Citation: Liu JW, Li YY, Wang MK, Yang JS. Combined prevention and treatment measures are essential to control nosocomial infections during the COVID-19 pandemic. World J Virol 2024; 13(2): 91286
URL: https://www.wjgnet.com/2220-3249/full/v13/i2/91286.htm
DOI: https://dx.doi.org/10.5501/wjv.v13.i2.91286